Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 May;13(3):419-423.
doi: 10.1177/1932296819843398. Epub 2019 Apr 11.

Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices

David C Klonoff  1
Affiliations
Editorial

Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices

David C Klonoff. J Diabetes Sci Technol. 2019 May.
No abstract available

Keywords: FDA; accuracy; blood glucose monitor; clinical trial; surveillance.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DCK is a consultant to Abbott, Ascensia, EOFlow, Lifecare, Merck, Novo Nordisk, Roche, and Voluntis.

Comment on

References

    1. Philis-Tsimikas A, Stratton I, Troelsen LN, et al. Efficacy and safety of degludec compared to glargine 300 units/mL in insulin-experienced patients with type 2 diabetes: trial protocol amendment (NCT03078478). J Diabetes Sci Technol. In press. - PMC - PubMed
    1. Krouwer JS. Why the new FDA glucose meter POCT guidance is disappointing. J Diabetes Sci Technol. 2017;11:1274. - PMC - PubMed
    1. Pfützner A, Demircik F, Valeria K, et al. System accuracy assessment of a blood glucose meter with wireless internet access associated with unusual hypoglycemia patterns in clinical trials. J Diabetes Sci Technol. In press. - PMC - PubMed
    1. Demircik F, Kirsch V, Ramljak S, et al. Laboratory evaluation of linearity, repeatability, and hematocrit interference with an internet-enabled blood glucose meter. J Diabetes Sci Technol. In press. - PMC - PubMed
    1. Klonoff DC, Lias C, Beck S, et al. Development of the diabetes technology society blood glucose monitor system surveillance protocol. J Diabetes Sci Technol. 2016;10:697-707. - PMC - PubMed